|
|
The JIKEI trial
F. Boutitie
,
François Gueyffier
,
Jm. Achard
The Lancet, 2007, 370, pp.1825-1826
Article dans une revue
hal-00434571v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response? A meta-analysis
Julie Coton
,
Ha-Hai Le
,
Victor Veuillet
,
Perrine Janiaud
,
Michel Cucherat
,
et al.
Article dans une revue
hal-02112948v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Le Projet INDANA : Méta-analyse sur données individuelles des essais cliniques du traitement médicamenteux de l'hypertension artérielle
François Gueyffier
Pharmacologie. Université Claude Bernard Lyon 1, 1997. Français. ⟨NNT : ⟩
Thèse
tel-02632535v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Expected impact of a public health intervention in the presence of synergistic risk factors
Hadrien Charvat
,
François Gueyffier
,
Aurélien Belot
,
Pascal Roy
Article dans une revue
istex
hal-02168099v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
M. Rehman
,
B.V. Tudrej
,
J. Soustre
,
M. Buisson
,
P. Archambault
,
et al.
Article dans une revue
hal-01808205v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Rémy Boussageon
,
Irène Supper
,
Theodora Bejan-Angoulvant
,
Nadir Kellou
,
Michel Cucherat
,
et al.
Article dans une revue
inserm-00700878v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome
J.-G. Wang
,
J.A. Staessen
,
S. Franklin
,
R. Fagard
,
François Gueyffier
Hypertension, 2005, 45(5), pp.907-913
Article dans une revue
hal-00427867v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The lower the better: Does simplicity lead to absurdity?
François Gueyffier
,
Jm. Wright
Editorial comment, 2006, 24(3), pp.431-433
Article dans une revue
hal-00427877v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Safety of computerized drug management: a case report
K.-A. Nguyen
,
T. Vial
,
François Gueyffier
,
S. Marignier
,
P. Cochat
,
et al.
British Journal of Clinical Pharmacology, 2006, 63, pp.245-246
Article dans une revue
hal-00428015v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets
François Gueyffier
,
M.I. Perez
,
Jm. Wright
,
I. Marchant
,
V.M. Musini
,
et al.
Journal of Hypertension, 2011, 29, pp.171-175
Article dans une revue
hal-00697933v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Estimation of attributable burden of disease: authors' reply
François Gueyffier
,
Jm. Wright
Journal of Hypertension, 2006, 24 (5), pp.933-936
Article dans une revue
hal-02313858v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Multivariate meta-analysis using individual participant data
R. D. Riley
,
M. J. Price
,
D. Jackson
,
M. Wardle
,
François Gueyffier
,
et al.
Article dans une revue
hal-02045096v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
Esber S Saba
,
Lucie Gueyffier
,
Marie-Laure Dichtel-Danjoy
,
Bruno Pozzetto
,
Thomas Bourlet
,
et al.
Article dans une revue
hal-00972341v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Effet antalgique aigu du paracétamol en soins primaires : des preuves incomplètes
Marion Gougain
,
Moreau Alain
,
Rémy Boussageon
,
Gisèle Pickering
,
François Gueyffier
Article dans une revue
halshs-01866986v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The IDEAL Study : Towards Personalized Drug Treatment of Hypertension
T. Bejan-Angoulvant
,
J-P. Baguet
,
S. Erpeldinger
,
J-M. Boivin
,
A. Mercier
,
et al.
Article dans une revue
istex
hal-02297347v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Traitement anti-hypertenseur et tabac
R. Boussageon
,
G. Grand
,
François Gueyffier
Article dans une revue
hal-02297358v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
[Readability of informed consent forms for subjects participating in biomedical research: updating is required]
Adeline Paris
,
Jean-Luc Cracowski
,
Nadia Ravanel
,
Catherine Cornu
,
François Gueyffier
,
et al.
La Presse Médicale, 2005, 34 (1), pp.13-8
Article dans une revue
inserm-00321527v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Efficiency of physical therapy on postural imbalance after stroke: study protocol for a systematic review and meta-analysis
Aurélien Hugues
,
Julie Di Marco
,
Perrine Janiaud
,
Y Xue
,
Jennifer Pires
,
et al.
Article dans une revue
inserm-01576495v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population
R. Kahoul
,
François Gueyffier
,
E. Amsallem
,
M. Haugh
,
I. Marchant
,
et al.
Article dans une revue
hal-02046795v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
C. Scholtes
,
P. Andre
,
C. Trepo
,
C. Cornu
,
Laurent Remontet
,
et al.
Article dans une revue
istex
hal-02278582v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.
Caroline Guignant
,
Alain Lepape
,
Xin Huang
,
Hakim Kherouf
,
Laure Denis
,
et al.
Article dans une revue
inserm-00622817v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Problématique des cibles de pression artérielle
R. Boussageon
,
T. Bejan-Angoulvant
,
François Gueyffier
Revue médicale Suisse, 2011, pp.873
Article dans une revue
hal-02303189v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Some reflexions about double blind
R. Boussageon
,
François Gueyffier
,
A. Moreau
,
Y. Gansel
,
V. Boussageon
L'Encéphale, 2007, 34(4), pp.347-351
Article dans une revue
hal-00434916v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study
C. Vale
,
L. Rydzewska
,
M. Rovers
,
J. Emberson
,
François Gueyffier
,
et al.
Article dans une revue
hal-02019003v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Causality and statistical association (2) Mechanical determinism and stochastic model
François Gueyffier
,
Michel Cucherat
Revue du Praticien (La), 2003, 53, pp.933-936
Article dans une revue
hal-00427339v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design
G. Grenet
,
A. Lajoinie
,
S. Ribault
,
G. B. Nguyen
,
T. Linet
,
et al.
Article dans une revue
hal-01848312v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Do We Need to Assess the Effect of Treatment Withdrawal? The Paradigm of Life-Long Prevention
François Gueyffier
,
T. Bejan-Angoulvant
Journal of the American Hearth Association, 2007, --, pp.219-226
Article dans une revue
hal-00434915v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Critères intermédiaires et critères de substitution
Behrouz Kassai
,
François Gueyffier
,
J-P. Boissel
Médecine Thérapeutique, 2007, 13(4), pp.279-286
Article dans une revue
hal-00697981v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies
I. Marchant
,
Patrice Nony
,
Michel Cucherat
,
J-P. Boissel
,
S.R. Thomas
,
et al.
Article dans une revue
hal-00698042v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Individual patient data meta-analysis of survival data using Poisson regression models.
Michael Crowther
,
Richard Riley
,
Jan Staessen
,
Jiguang Wang
,
Francois Gueyffier
,
et al.
Article dans une revue
inserm-00720880v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|